Patrick Sullivan

Patrick Sullivan has an extensive background in marketing and commercialization within the pharmaceutical industry, having held key leadership roles at several prominent companies. At Corium Therapeutics, Patrick served as Vice President of Marketing for the Neurology portfolio, overseeing the US commercialization of innovative therapies for ADHD and dementia. Prior experience includes a notable tenure at AstraZeneca as Global Commercial Head and Executive Director, where Patrick led the global efforts for Evrenzo, a groundbreaking treatment for anemia. Additional roles at Shire Pharmaceuticals, Adolor, and Novartis highlight a strong focus on brand strategy and market introduction across various therapeutic areas. Patrick holds a Bachelor of Science in Business Administration from Widener University and an Executive MBA in Healthcare Marketing from Saint Joseph's University.